View all veterinary jobs
VetSurgeon.org publishes a curated feed of veterinary news for practising veterinary surgeons, with a primary focus on the UK profession.
We select stories based on their practical relevance, clinical interest, or professional significance — filtering out noise so busy vets can stay informed quickly.
Our coverage includes:
We report across all areas of practice, including companion animal, farm, equine and exotic species.
Our editorial approach is deliberately selective and concise. We prioritise clarity and relevance over volume, aiming to make each story worth your time.
You can follow VetSurgeon News by subscribing to the daily, weekly or monthly email digest, or via our channels on Facebook and LinkedIn.
Ludivine, who graduated in 2008, has come over from America to take up the new post, having just completed a three-year residency at the University of Pennsylvania in Philadelphia.
She said: "I’m really enjoying working as part of a great team and working with the various different disciplines here.
"I’m passionate about my ECC speciality and I have a keen interest in respiratory diseases, trauma and acid base disturbances.
"I also like teaching and being updated about the most recent studies in ECC to ensure I can deliver the most up-to-date care possible for our patients."
Ludivine was born in France and originally studied at her home town university in Lyon, progressing to a rotating internship there after graduation.
In 2012, she worked as an emergency veterinary surgeon in several general practices across France and Switzerland, before moving to the United States in 2014 to see how ECC medicine was practiced overseas.
First, she undertook an ECC internship at the University of California, followed by a three-year residency at the University of Pennsylvania.
Away from work, Ludivine enjoys horse riding, running, work-outs and practising her skiing in the French Alps. She also has two dogs Dalhi her Golden Retriever and Baya her German Shepherd.
For more information, visit www.willows.uk.net/en-GB/specialist-services.
The patient was a four-year-old Labrador called Vinny who, in 2019, became the first dog in the UK to receive a BioMedtrix canine ankle replacement system, implanted by Wear's Head of Orthopaedic Surgery, RCVS Specialist Neil Burton, assisted by Maciej Krukowski.
That first surgery, on Vinny’s right ankle, was successful. However, two years later he needed similar treatment to his left leg.
Neil said: “Vinny first presented to us at Wear Referrals in 2019 with hind limb lameness.
“He was diagnosed with osteoarthritis in his hock joints bilaterally due to a developmental condition called osteochondrosis of the talus causing him ongoing pain and lameness. We operated on the right ankle, with Vinny becoming the first dog in the UK to have this ankle replacement system placed.
“Vinny was significantly more comfortable on this limb postoperatively but his lameness progressively worsened in the left hind limb. The decision was made to perform the same surgery on the left ankle, making Vinny the first dog in the world to have this surgery performed bilaterally.
“Vinny has made another fine recovery from surgery and is now off medication, meaning he can exercise unrestricted and pain-free without a lifetime reliance on painkilling drugs.
“For our team at Wear to be able to offer him this pioneering surgery has been a great opportunity. He’s now a unique case, being both the first UK recipient of this BioMedtrix joint replacement as well as the world's first bilateral ankle replacement with the same system.”
For more information, visit www.wear-referrals.co.uk.
Supplies of the vaccine, which is indicated for the active immunisation for horses against equine arteritis, ran low at the end of last year when Zoetis' existing stock was due to expire without any new stock in place.
For further information, contact your Zoetis Account Manager or the Zoetis Technical Team on customersupportUK@zoetis.com or 0845 300 9084 choosing option 1.
The report also revealed the devastating impact on overworked veterinary staff, with some left in tears by abusive owners venting their frustration at being unable to find care for their animal.
Anecdotally, the problems highlighted by ITV News are being seen elsewhere in the country, with more and more vets now starting to question whether or not the current requirement to provide out of hours care is sustainable in a world where there are more clients who increasingly expect flea treatment advice and other non emergency situations to be dealt with at 3:00am in the morning.
Various solutions have been proposed in a forum discussion on VetSurgeon.org, including the removal of the requirement to provide an OOH service, for the RCVS to give vets the confidence to say no to non emergencies, a change to the CoPC to require vets to provide emergency care within 24 hours, not 24 hours a day, a requirement for new grads to undertake OOH as part of their PDP, and/or a requirement for OOH centres to have 3 vets on duty at any one time (which could improve working conditions).
As the ITV report pointed out, the fundamental issue is one of a shortage of supply over demand, for which there is no overnight fix. However, many feel that reducing the demands of providing OOH could ease the situation considerably.
Mr Georgescu faced three sets of charges:
The first was that in April 2024 at Newcastle Magistrates’ Court, he pleaded guilty to driving a car when the proportion of the controlled substance Benzoylecgonine (the main metabolite of cocaine) exceeded the specified limit contrary to the Road Traffic Act 1988 and the Road Traffic Offenders Act.
He was disqualified from driving for 20 months, fined £634, ordered to pay £254 victim surcharge and £150 costs.
The second and third charges were that he was misleading and/or dishonest with the RCVS when he was asked to provide information about the circumstances leading to his conviction.
In correspondence with the College, he claimed that the incident happened on his day off, when he was in fact due to work that day.
He also submitted – or allowed to be submitted – a false staff rota for the day of his arrest.
The Disciplinary Committee found the charges against Mr Georgescu proven on the basis of the certificate of conviction and his admission, prior to the hearing, that he had given false information.
The Committee then considered whether the three charges amounted to serious professional misconduct.
The Committee considered the fact that Mr Georgescu was driving, and intending to work, while he was seven times over the prescribed proportion of Benzoylecgonine allowed to be in in his bloodstream.
Paul Morris, chairing the Committee and speaking on its behalf, said: “With regard to the impact this conduct would have on right thinking members of the public, Dr Georgescu himself said, when cross examined, that were he standing in the shoes of an owner of an animal he was going to treat that day with the knowledge that he had in his blood more than 7 times the prescribed limit of a prohibited drug he “would not be comfortable for sure” and would cause such persons to “lose trust”.
“Having regard to the above facts and matters the Committee has no hesitation in concluding that the facts relevant to his commission of the offence in Charge 1 were so serious and presented such prospective risks to other road users that it renders the respondent unfit to practise as a veterinary surgeon.”
Charges 2 and 3 were considered together, with the Committee again finding serious professional misconduct on the basis that Mr Georgescu had set out to lie to the RCVS and had continued and repeated the lie for a period of six months.
The Committee identified a number of aggravating features in his conduct including the fact it was premeditated, entailed sustained and repeated dishonesty, involved wilful disregard for the role of the RCVS as the veterinary regulator and that admissions were only made when he realised he couldn’t sustain his falsehoods any longer.
Finally, having found that all charges were proven and amounted to serious professional misconduct, the Committee decided that suspending Mr Georgescu from the Register of Veterinary Surgeons would be adequate to protect the welfare of animals, maintain public confidence in the profession, and declare and uphold proper standards of conduct.
Paul Morris added: “The misconduct of the respondent is serious but his misconduct falls short of being fundamentally incompatible with remaining on the Register.
"He does have insight into the seriousness of his misconduct and there is, in the judgement of the Committee, no significant risk of repeat misleading behaviour.
"The Committee also considers that the respondent will be fit to return to practice after the period of suspension in question.
“The Committee did consider striking the respondent from the Register but determined that this sanction would be unduly punitive and deprive the public and the profession of an otherwise competent veterinary surgeon.
“The Committee has reflected carefully on the question of how long the period of suspension should be and has determined that it should be a period which is not so long that it will result in the loss of the respondent to the profession which he professes to love and in which his referees assert he is a capable and caring veterinary surgeon.”
www.rcvs.org.uk/disciplinary
Batches 060K80412C1A-UK1-2 and 060K80412A1C-UK1-2 (expiry 12/06/2019) have been recalled due to incorrect storage requirements during shipment.
For further information, contact Jerome Martineau at: jerome.martineau@filavie.com, or telephone: +33 2 41 754616
The award recognises an exceptional farm vet who has been working in the dairy industry for three to five years and contributed significantly to the health and wellbeing of the herds under their care.
Rob joined LLM Vets after graduating from Cambridge University Vet School in 2017. He has particular interests in lameness, calf rearing and housing design. He said: “Since joining LLM, I have thrown myself into all aspects of the practice – from the Agricultural Show season to driving LLM’s BVD eradication efforts and revamping our herd health planning scheme. My role in practice management is also growing. I currently oversee work for the Johnes CHeCS programme and help to guide our industry-leading team of VetTechs."
He added: “I find the interaction between dairy cattle and their environment fascinating and, following some specialist training I undertook with the Dairyland Initiative in Wisconsin, I’ve been helping our farmers to make major changes to their cow and calf housing, particularly by improving ventilation.”
CREAM judge Rob Drysdale said: “Rob Hall really stood out because of the additional services he’s trying to offer, for instance, getting involved in the Stamping Out BVD campaign and utilising his specialist skills in calf housing ventilation to increase welfare standards. Rob would be a real asset to any farm or vet business.”
Charlotte Read, Key Account Manager – Farm, at Krka, added: “Newly qualified vets represent the future of this exciting and rapidly-evolving profession so we are particularly delighted to have the opportunity to highlight their achievements. Krka is proud to support the UK’s dairy sector and we congratulate both Rob and Rupert on the huge contribution they are making to their clients and their practices.”
The company says that as soon as it discovered the unauthorised external access to its systems, it took them offline and started working to contain the threat.
Specialist third party consultants have been engaged to investigate the nature and extent of the incident and CVS has also informed the relevant authorities, including the Information Commissioner’s Office, because of the risk of malicious access to personal information.
The company says the majority of IT services for its practices and business functions have now been restored, but due to the increased levels of security and monitoring, some systems are not working as efficiently as before.
CVS also says that as a result of the incident, it is bringing forward plans to migrate its practice management system and related IT infrastructure to the cloud.
Analysis of the incident is ongoing and CVS says it will provide a further update in due course.
The Good Veterinary Workplaces Voluntary Code sets out various criteria for what makes a good workplace, based on a new evidence-based BVA policy position.
The code is accompanied by a workbook which veterinary teams can work through together and consider how they might meet a range of criteria. They can also download, sign and display a Voluntary Code poster signalling their commitment to working towards being a good veterinary workplace.
Teams will be asked to assess what they already do well in areas including health and wellbeing, diversity and equality, workload and flexibility, and providing opportunities for personal and career development, as well as identifying areas for improvement and any HR and management processes that need to be put in place to achieve a positive workplace culture.
At the same time, the BVA has also launched its Good Veterinary Workplaces policy position, a paper which offers 64 recommendations for employers and staff on how to offer a fair and rewarding work environment where everyone feels valued.
The BVA says it decided to develop the Good Veterinary Workplaces policy off the back of an extensive body of work looking at workforce issues in the profession, including recruitment and retention challenges, a lack of diversity across the workforce, and general high levels of stress and burn-out in veterinary teams.
The joint BVA/RCVS-led Vet Futures project identified the need to explore the work-related challenges facing vets and take action to create a sustainable and thriving workforce that can maximise its potential.
Gudrun Ravetz, Chair of the Good Workplace Working Group, said: “I’m absolutely delighted to see the launch of our valuable and comprehensive policy, which sets out a vision of the good veterinary workplaces that we should all be striving to create across the profession. This vision has been shaped by valuable contributions from across the veterinary community, and it’s also been really useful to draw on good practice in the wider world of work.
“Each and every one of us deserves to work in a setting where we feel valued, supported and fairly rewarded for the contribution we make, but sadly this isn’t the reality for all veterinary professionals. By setting out the steps that all veterinary workplaces can take to offer a more welcoming and inclusive environment, with measures in place to help them address issues and continue to improve, we hope to see more workplaces where staff can thrive and enjoy a fulfilling career.”
Daniella Dos Santos, BVA Senior Vice President, said: “It’s time for us all to take action to create a culture shift in veterinary workplaces. That means taking positive steps so that diversity and inclusion is championed at all levels, all team members have access to personal and professional development opportunities, and there is recognition that prioritising staff wellbeing is good for businesses.
“In creating the Voluntary Code and workbook, we’ve purposefully made this something that isn’t driven from the top down but is instead something that everyone in the team can feel empowered to feed into and sign up to. This is a golden opportunity for our profession to take ownership of our workplaces, improve conditions, and make sure that we have positive working environments in which we can all take pride.”
Vétoquinol has announced the return of Navilox powder (isoxsuprine hydrochloride), the only medication specifically licensed in the UK for use in cases of navicular disease in horses.
Navicular disease is a chronic degenerative condition of the navicular bone and associated structures. It is a syndrome with a complex pathogenesis which combines various underlying causes. Vétoquinol says it is a common cause of lameness in the middle aged riding horse.
Robert Simpson, Navilox Product Manager said: "Navilox has been sorely missed by equine vets in the UK which is why I am thrilled to be able to announce that it is available again."
To order Navilox powder, call Vétoquinol on 01280 825424 or contact your wholesaler directly.
For the research, the medical histories of 188 Basset Hounds and 270 Dachshunds presenting to CVS’ Dovecote Veterinary Hospital and Chestergates Veterinary Specialists, and the University of Ghent were retrospectively assessed.
Information included signalment, whether the dog had received a diagnosis of TL-IVDE, the duration of clinical signs, affected discs and anatomical region and the neurological grading at presentation and discharge.
Basset Hounds and Dachshunds are both chondrodystrophic breeds which are predisposed to IVDE.
However, the study found 77.4% of Dachshunds had presented with IVDE, compared to only 36.2% of Basset Hounds.
Dachshunds also presented earlier (66.5 months) compared to Basset Hounds (median 87.5 months).
Dachshunds had a lower proportion of midlumbar IVDE and were more frequently non-ambulatory at discharge than Basset Hounds.
In addition, Dachshunds were more likely to be paraplegic without sensation at presentation than Basset Hounds (16/154 Dachshunds compared to just one Basset).
The Basset Hound is the largest chondrodystrophic breed and the physical characteristics of this larger body conformation may have benefits, with previous studies suggesting the protective effects of being a larger dog2.
One hypothesis is whether breed conformation and anatomy – the relative height/weight ratio - influences the severity and occurrence of IVD and points to a link between the size of the patient and the space in the vertebral canal.
A smaller spinal cord versus vertebral canal ratio in the Basset Hound may indicate a less compressive lesion.
Sergio Gomes, Head of Neurology and specialist in veterinary neurology at Dovecote Veterinary Hospital, who led the study, said: “This is the first time that IVDE data for Basset Hounds has been directly compared with that for Dachshunds.
“We now need to look closely at the conformation and anatomy of the Basset Hound to see what learnings we can take.
"This could have positive future implications for Dachshund breeding programmes, so that longer term we can try to minimise this painful and common canine condition.”
References
The charge was that between June and October 2022, the vet imported or arranged for the importation of approximately 1950 to 2010 tablets of a medicine which purported to be norethisterone when there had been no Special Importation Certificate (SIC) issued by the VMD.
The vet was also charged with supplying or arranging the supply of the medicine to a number of greyhound trainers, with a view to the medicine being administered to greyhounds.
Finally, the vet was also charged that he knew there was no SIC, that the medicine contained substances other than norethisterone, that he had made no assessment of whether any or all of the other substances were appropriate for administration to the greyhounds, and that the Greyhound Board of Great Britain did not permit greyhounds to race with the other substances found in the medicine in their system.
The vet admitted all the charges against him at the start of the hearing.
The Committee said aggravating factors included risk of injury to an animal or human, recklessness, and break of client trust.
It also noted that despite his practice being rated 4 out of 5 in a 2025 Veterinary Practice Premises Inspection Report in relation to the VMD’s most recent inspection of his practice, the report raised four matters relating to the issuing and labelling of medication.
In mitigation, the Committee accepted that the vet had imported the norethisterone from India with good intentions, in that he believed he was assisting the greyhounds to keep them racing.
It also noted that while this was not an isolated incident, he only ordered the norethisterone twice and supplied it over a five-month period in 2022.
He had also practised without incident since importing and supplying the norethisterone.
The Committee decided that the conduct amounted to serious professional misconduct, and that he had breached sections 1.5, 6.4 and 6.5 of the Code of Practice for Veterinary Surgeons in 2022.
Deciding the sanction, the Committee also noted that the vet had a previous disciplinary finding against him relating to findings of dishonesty regarding his communications with the Animal and Plant Health Agency in the taking of blood samples for horses due to be exported to Serbia, which resulted in a six-month suspension from the Register.
Neil Slater, chairing the committee, said a six-month suspension would allow the vet time to “develop insight and understanding of the importance of regulatory compliance” and reflect on his practice, while also signalling to the profession and the public that such compliance is essential.
He said the committee had considered whether removal from the register was warranted, particularly given a previous similar disciplinary finding, but concluded that this could be “career ending”. A longer suspension was also ruled out on the same basis.
However, the committee expressed significant concern that the case, alongside the earlier finding, demonstrated a “persistent disregard for regulatory legislation”. It said the sanction imposed was necessary to protect animal welfare and maintain confidence in the profession.
The vet will be suspended for six months following the expiry of the appeal period.
https://www.rcvs.org.uk/veterinary-professionals/conduct-and-guidance/concerns-for-veterinary-professionals/disciplinary-committee-hearings
Stelfonta is licensed for the treatment of non-resectable, non-metastatic (WHO staging1) subcutaneous mast cell tumours (MCTs) located at or distal to the elbow or the hock, and non-resectable, non-metastatic cutaneous MCTs in dogs. Tumours must be less than or equal to 8cm3 in volume and must be accessible to intratumoural injection.
The company says that a single intratumoural treatment has been seen to destroy the tumour completely in 75% of observed cases.
The active ingredient in Stelfonta is tigilanol tiglate, a compound extracted from Fontainea picrosperma, a shrub found in the Australian rain forest. According to the company, it works largely through specific protein kinase c (PKC) activation, in which it locally stimulates the immune system, resulting in destruction of the tumour and the tumour’s blood supply, followed by rapid healing of the site with minimal scarring.
Virbac says that generally, dogs do not require sedation or local or general anaesthesia during treatment.
Dr Neil Mottram MRCVS, Technical Product Manager at Virbac said: "Stelfonta is an innovative yet simple treatment which provides a high tumour elimination rate, rapid healing and a speedy return to a good quality of life for the pet. In the cases studied, the tumour was destroyed in seven days and full wound healing observed in 96.5% of cases, with no significant adverse effects on the dog.
“The effects of Stelfonta really do need to be seen to be believed."
Reference
Pedigree has announced that it has raised over £160,000 to help the thousands of dogs abandoned every year in the UK, through its charitable initiative, The Pedigree Adoption Drive 2011.
Pedigree says its fundraising comes at a crucial time, as rescue centres' facilities across the country are severely suffering under the strain of the highest level of dog abandonment in over a decade.
The Pedigree Adoption Drive, which launched in mid-October, aims to raise awareness of the ever-increasing issues of dog abandonment and funds for the hundreds of rescue centres across the country that work tirelessly to find these dogs new loving homes.
Now in its fourth year, the campaign called upon dog lovers everywhere to show their support, by taking part in the world's first virtual dog walk around the web. In addition, consumers got involved in a host of other activities - donating via text message and online, to help the Drive reach this year's grant total.
The funds raised this year will be distributed through grants to 90 rescue homes across the country - including three special grants of £15,000 given to Bath Cats and Dogs Home, £20,000 given to North Clwyd Animal Rescue and £25,000 given Birmingham Dogs Home. Every grant will be put towards projects aimed at making tomorrow better than today for dogs - including the refurbishment of dilapidated kennel blocks, desperately needed veterinary facilities and the supply of essential surgical equipment.
TV presenter and vet Steve Leonard, who is the ambassador of this year's campaign, said: "The money raised from this year's Pedigree Adoption Drive is a great example of how we can achieve so much together to help take steps towards tackling the issue of dog abandonment. The grants awarded to rescue centres this year will make a big difference in helping to find many rescue dogs, the loving homes they deserve."
Katie Wragg, Pedigree Adoption Drive Brand Manager said: "In the last four year's we've raised over £1million for rescue centres supporting the country's abandoned dogs and despite the tough economic climate, the amazing public reaction has enabled us to really make a difference to the lives of abandoned dogs across the UK and help give them a bright future."
For more information on the campaign log on to: http://www.pedigreeadoptiondrive.com/
The RCVS has extended its alternative dispute resolution (ADR) trial until October 2015 and broadened its remit, allowing more cases to be considered.
The idea of the ADR is to provide an alternative form of resolution for the many concerns raised with the RCVS which do not meet the College's threshold for serious professional misconduct and are, therefore, not taken through its disciplinary process.
The trial, which was originally due to end in May 2015, aims to gather evidence needed to develop a permanent scheme.
As well as the time-frame being extended, the trial will now also be widened to include concerns raised about the treatment of horses and other equines - in addition to those raised about small animals.
The RCVS has also lowered the maximum financial award that can be recommended by the Ombudsman Services, a not-for-profit complaints resolution service which is administering the trial, to £3,000 for small animal cases. The maximum financial award that can be recommended by the Ombudsman Services in relation to equine cases remains at £10,000.
Nick Stace, RCVS Chief Executive, said: "The trial got off to a slower start than we expected and so we have decided to extend its length and breadth to allow more time and scope to gather the evidence and testimonies which we need to assess the trial.
"It's important to stress again that the trial is free, voluntary, as both parties must agree to take part, and that the recommendations made by the Ombudsman Services are not binding - it is up to either party as to whether they accept them."
The results of the trial will now be reported to the November 2015 meeting of RCVS Council. For further information about the ADR trial please visit www.rcvs.org.uk/adr
The group, which was founded over 70 years ago, now employs over 300 people, more than 85% of whom are female. Many occupy senior and leadership positions: 6 out of 13 of the partners are female.
Wendy Furness, a Partner at Scarsdale Vets said: "Scarsdale Vets represents a microcosm of how women’s roles could be in a world of gender equality in business.
"Here we have people in every role that you can imagine, from client-facing roles such as client care advisors, vets and nurses, to people that make the business function happen, such as marketing and finance managers.
"We want women to be inspired to be who they want to be. There are many roles that some people still first think of as male dominated, such as surgeons and farm or equine vets.
"However, we at Scarsdale Vets are challenging assumptions like these and looking for opportunities to make all roles visible to women.”
Wendy added: "Having women in leadership and senior roles is essential if women at the start of their careers are to succeed. We can be there to inspire the next generation to strive for these positions, if that is what they want, and see that it is made possible. We can also stand up and be counted if and when bias based on gender is observed."
To mark International Women’s Day, Scarsdale Vets is filling its social media channels with positive images of women, working in the diverse roles within the practice, challenging stereotypes about the veterinary roles available to women, influencing others positively, and celebrating the successes of the women in their team.
https://www.facebook.com/ScarsdaleVets/posts/2097073290308906
Photo: Rose Jackson MRCVS, a farm animal vet at Scarsdale Markeaton. Courtesy Scarsdale Vets.
Speaking at a press briefing at BSAVA Congress 2017, Dr Cathryn Mellersh, Head of Canine Genetics at the Animal Health Trust and a member of the WSAVA Hereditary Disease Committee, also urged vets not to shy away from telling owners if they have made a bad choice to try to deter them from making the same mistake again.
During her briefing Dr Mellersh explained that concern about hereditary disease, particularly in dogs, had grown significantly in recent years, thanks to an increased awareness of the risks it poses to animals.
Dr Mellersh also explained that this heightened awareness had coincided with a period of rapid progress in the development of tools and resources to tackle hereditary disease, including the online DNA database, created by the WSAVA’s Hereditary Disease Committee and supported by Mars Veterinary, which is accessible, free of charge to veterinary surgeons around the world.
She said: "We ask vets to advise breeders to use DNA test results to avoid breeding clinically affected dogs and to reduce the frequency of mutation within a breed, over time, without damaging genetic diversity. When selecting a test, it is important that they ensure that the test they are using is based on sound science and on the right mutation for the breed being tested."
Dr Mellersh also warned veterinary surgeons not to advise against breeding with carriers and said that dogs should not be excluded from breeding on the basis of a single mutation that they could test for. She said: "The disease mutation that the DNA test is for is not the only mutation that a carrier has. Most dogs carry at least 50 recessive mutations so, if carriers are not bred from and only clear dogs used then there is a risk that other mutations carried by these clear dogs will increase in frequency within the breed and new inherited diseases could emerge."
"The ranges of resources available to help vets in this area is growing all the time and includes the WSAVA database hosted by PennGen and a Kennel Club database which lists the DNA tests recommended or required by Assured Breeders.
"For those looking to increase their knowledge in this area, hereditary disease is one of the key issues to be discussed during this year’s WSAVA World Congress in Copenhagen from 25-28 September. Many of the world’s experts will be there and a full lecture stream is planned."
"I ask vets to work with us and to contribute to the very real progress that is being made to tackle hereditary disease, particularly in dogs. Advances in technology are driving this progress and it is also being supported by many breeders and by the Kennel Club.
"The greatest challenge we face is that of educating the general public that they should be mindful of hereditary disease when choosing a puppy and should seek out those whose breeders have had the appropriate DNA tests and clinical screens.
"It is, of course, not always possible to reach owners before they buy a puppy but should their dog later go on to develop a condition that is well-known in the breed, then I ask them to explain this to owners so that, should they buy another dog, they do not make the same mistake. As a vet, you will also often be the first port of call for advice by first time breeders and this gives you a golden opportunity to advise them as to the tests they should undertake and, depending on the results, whether they should go ahead with breeding or not.
"Working together as a profession, being willing to discuss difficult issues with owners and breeders and utilising the resources and tools created by organisations such as the WSAVA, are all required to ensure that we increase the momentum we are already achieving in tackling canine hereditary disease in the UK and around the world."
Genitrix has reformulated and repackaged its Lacto B range of broad spectrum probiotic supplements for the maintenance of normal digestive function in pets.
The products are provided in a powder formulation for direct application onto food or to be dissolved in water. They are available in five-day sachets or in 75g tubs suitable for longer term use.
Genitrix says that unlike single-strain formulations, the Lacto B range contains live freeze-dried cultures of three probiotic organisms which, when ingested, colonise the gut, helping to re-establish normal function. The three strains of probiotic organisms occupy the same sites in the gut as certain pathogenic bacteria thus preventing their attachment.
Indicated for dogs, cats, rabbits, rodents, reptiles and birds, the Lacto range is formulated to provide a guaranteed concentration of 1x109 CFU/g probiotic organisms.
Genitrix suggests that the Lacto B range can be particularly helpful in:
Rob Watkins, Marketing Director at Genitrix, said: "The Lacto range has been tried and trusted in small animal practice for twelve years and feedback shows that its multi-species indication make it a flexible and cost-effective solution."
"With its new formulation and new packaging, we believe it will prove even more attractive as a high potency probiotic supplement."
For more information, please click here.
The journal publishes original peer-reviewed papers of international or global significance that improve the veterinary care and welfare of domestic cats.
Until this year, access to JFMS for most veterinary practitioners was dependent on membership to the International Society of Feline Medicine (ISFM) or the American Association of Feline Practitioners (AAFP), or a separate paid subscription.
Now that the journal is open access, there are no restrictions on who can access the journal and all articles past and present are free to view.
The journal's editors say that making it open access greatly improves their ability to improve the health and welfare of cats by providing high-quality peer-reviewed information.
The AAFP and ISFM say they have already seen the positive impact this has had, with low- and middle-income countries now accounting for a quarter of the 20 most common geographic locations for visitors to the JFMS website.
Head of ISFM Nathalie Dowgray said: "Transitioning JFMS to an open access journal helps ISFM fulfil our parent charity’s (International Cat Care) mission of creating a cat friendly world through ensuring the latest knowledge in feline medicine and welfare is available to the global veterinary community."
For those interested in submitting to JFMS, authors can get a 50% discount on the article processing charge until 4 July 2023; after this date, a 22% discount will be in place for authors who are a member of ISFM or the AAFP.
Click here for more information about submitting an article to JFMS: https://journals.sagepub.com/author-instructions/JFM
https://journals.sagepub.com/home/jfm
Clare graduated from the University of Glasgow in 1991 and, following an internship at the University of Pennsylvania and general practice in Cambridgeshire, she completed a BSAVA/Petsavers Residency and was Staff Clinician in Neurology at the Royal Veterinary College.
Aged 26, she became the youngest ever Diplomate of the European College of Veterinary Neurology and three year later became a RCVS Specialist.
For 16 years, she operated a neurology and neurosurgery referral service at the Stone Lion Veterinary Hospital in Wimbledon and was awarded a PhD from Utrecht University in 2007.
Clare joined Fitzpatrick Referrals and the University of Surrey in 2013, was made a Fellow of the Royal College of Veterinary Surgeons in 2016 and awarded a Professorship of Veterinary Neurology in 2018.
Clare was made a Fellow of the Royal College of Veterinary Surgeons in 2016 in recognition of her meritorious contribution to the profession, including 25 years’ research into ‘Chiari-like malformation and syringomyelia’ in dogs.
Clare said: “I will be building and strengthening the neurology service at Wear to make it not just the leading centre in the North East, but in Europe.
“I love collaborating with others to find answers to the clinical problems we face and so, as well as potential partnership with my colleagues in the other disciplines at Wear, I hope to initiate or contribute to other multi-centre studies through the Linnaeus group.
“I am passionate about teaching and learning through collaboration, and I hope to bring multi-disciplinary rounds to the practice including neuro-radiology-neuropathology and neurology- behaviour.”
Evidence given to the Women and Equalities parliamentary committee by BUPA last year suggested that 900,000 women may have left the UK workforce in recent years as a result of menopausal symptoms.
With the veterinary profession increasingly female in composition it is hoped that the hub will support more women to stay in the profession and therefore retain their vital skills in the workforce.
Statistics from the Voice of the Veterinary Profession Spring 2023 survey showed that only 14% of vets are aware of a menopause policy at their workplace, while 46% say there is no policy and 39% are unsure.
The survey also revealed that only 59% of vets would feel confident supporting a colleague experiencing menopause.
The new menopause hub provides veterinary specific menopause content to support everyone working in practice including colleagues, managers and partners of people experiencing menopause.
BVA recently signed the Menopause Workplace Pledge – committing to take positive action to make sure everyone experiencing menopause is supported - and is now urging other veterinary employers to do the same.
British Veterinary Association Junior Vice President Anna Judson, said: “We know that menopause is of growing importance to our profession, with female vets now making up more than half the workforce, and we know that issues with managing menopause symptoms prompt a significant number of women to move away from clinical work.
“As part of our Good Veterinary Workplaces campaign we’re committed to supporting all veterinary staff affected by menopause, allowing them to remain in post, and to providing relevant resources to improve employer engagement in this area.
"We urge all veterinary workplaces to sign the pledge and consider what more they could be doing to support their staff in managing menopause symptoms in the workplace.”
BVA members experiencing menopause are also eligible for 3 months free access to the Stella app, which includes a personalised plan to manage your specific symptoms, real-life coach support, menopause resources, progress tracking, and a supportive community.
Content on the Stella app is created in collaboration with a range of clinicians and healthcare professionals and goes through a rigorous fact-checking and review process.
https://www.bva.co.uk/menopause-hub
Equibactin oral powder comes in a 60g sachet, which Dechra says is the scientifically considered accurate dose1 for two daily treatments for a 600kg horse. The sachets come in a box of 10, which is sufficient for the twice daily treatment of a 600kg horse for five days.
The combination of sulfadiazine and trimethoprim antibiotics (known as TMPS) has a broad spectrum of uses and can be used to treat equine infections associated with Streptococcus and Staphylococcus aureus, gastrointestinal infections associated with E. coli and urogenital infections associated with beta-hemolytic streptococci.
Emma Jennings, Equine and Food Producing Animal Brand Manager, said: “Our product allows for twice daily 30mg/kg treatments, making the treatment of large horses easier and ensuring they receive the correct dose, which is crucial when it comes to tackling antibiotic resistance.”
She added: “TMPS is the only registered oral antibiotic available for use in horses and it is recommended as the first line of treatment for ‘common’ equine bacterial infections including those which have developed through wound infections or open or drained abscesses.2,3
“Effective antibiotics are an important part of the veterinarian’s arsenal when it comes to treating a variety of common bacterial infections in horses. But in recent years, the emergence of drug resistant bacteria has meant that extra precautions must be taken to prevent underdosing - one of the prominent causes of drug resistance.”
Equibactin oral powder is available now in the UK and Ireland. For more information visit www.dechra.co.uk.
Mr Makepeace faced five charges.
The first charge was that in 2022 Mr Makepeace was convicted at Scarborough Magistrates Court of assaulting by beating his ex-partner.
He was sentenced to a community order and a curfew order and was ordered to pay a £95 surcharge and £85 in costs.
It was alleged that the conviction rendered him unfit to practise as a veterinary surgeon.
The second was that in August 2022, Mr Makepeace submitted a character reference which purported to have been written by his ex-partner saying that they "still live happily together", when this was untrue. It was also alleged that the reference purported to have been signed by Mr Makepeace's ex-partner when he knew that was not the case.
The third charge alleged that Mr Makepeace had sent WhatsApp messages to his ex-partner which were offensive, insulting, abusive, threatening and/or intimidating.
The fourth charge was that was a repetition of the second.
The fifth and final charge was that in relation to charges 2 and 4, that Mr Makepeace’s conduct was misleading and/or dishonest; and that it is alleged that in relation to charges 2,3,4 and/or 5, whether individually or in any combination, that Mr Makepeace was guilty of disgraceful conduct in a professional respect.
The first charge was proven by virtue of a certified copy of the memorandum of an entry in the Magistrates’ Court register.
Mr Makepeace also admitted the facts of all the other charges, meaning they were found proven by admission.
In terms of the conviction, the Committee assessed the incident to be serious – the assault was prolonged, involved strangulation and biting which led to physical injuries, and involved a pursuit.
This was found by the Committee to bring the reputation of the profession into disrepute.
The Committee therefore found that the conviction rendered Mr Makepeace unfit to practise.
With regard to the remaining charges, the Committee found Mr Makepeace’s behaviour serious, saying that it showed a blatant and wilful disregard of the role of the RCVS and the systems that regulate the veterinary profession, and that his actions were intended to dishonestly subvert that process.
The Committee considered that his actions fell sufficiently below the standards expected in terms of honesty and integrity, as well as in terms of the behaviour expected of a registered professional.
All this constituted disgraceful conduct in a professional respect.
When making a decision on the appropriate sanction, the Committee took into account evidence from Mr Makepeace, two character witnesses, and a document bundle including evidence of training, continuing professional development (CPD) and other testimonials.
Aggravating factors taken into account were:
Mitigating factors taken into account were that Mr Makepeace made full admissions at the start of the hearing; he expressed remorse; was shown to be of previous good character; that there had been a significant lapse of time since his conviction; he had made subsequent efforts to avoid repetition of the behaviour which led to the conviction; the financial impact upon Mr Makepeace if he was prevented from being able to practise; and the testimonials.
Neil Slater, Chair of the Disciplinary Committee and speaking on its behalf, said: “The Committee’s view was that the demands of the public interest in this case were high, and in light of all of the circumstances, removal from the register was the only means of upholding the wider public interest, which includes the need to uphold proper standards of conduct and performance, and to maintain confidence in the profession and its regulation.
“The Committee therefore decided to direct that the respondent should be removed from the Register.
"In coming to this decision, the Committee carefully applied the principle of proportionality and took into account the impact of such a sanction on the respondent’s ability to practise his profession, as well as the financial impact upon him, taking into account his evidence in this regard.
“However, the Committee determined that the need to uphold the wider public interest outweighed the respondent’s interests in this respect.
"In light of the gravity of the conduct, and all of the factors taken into account, any lesser sanction would lack deterrent effect and would undermine public confidence in the profession and the regulatory process.
"Removal was the only appropriate and proportionate sanction.”
https://www.rcvs.org.uk/concerns/disciplinary-hearings
Dechra Veterinary Products has relaunched Oxyglobin after concluding an exclusive agreement to supply the product across the UK and Republic of Ireland.
Oxyglobin is used to stabilise anaemic dogs until the underlying condition can be controlled and the animal's body can produce its own new red blood cells.
Dechra says the treatment, which is now available in both 125ml bags and individual 60ml transfusion bags, maintains tissue oxygenation even when there is severe stenosis of blood vessels. It has a viscosity which is more than water but less than blood for ease of flow through vessels, and also increases circulatory volume.
Dechra Veterinary Products Brand Manager, Carol Morgan, said: "Veterinary professionals have been waiting for Oxyglobin to come back onto the market for some time and we're delighted to be able to relaunch it in the UK and Republic of Ireland.
"It was withdrawn from the market in 2010 when OPK Biotech acquired the assets of manufacturer Biopure Corporation in 2009. But this year, OPK Biotech resumed the manufacture of Oxyglobin and we have stocks available to practices from this month (FEB)."
"Oxyglobin turns around clinical outcomes for dogs with anaemia, regardless of the cause of the condition, which is why it is the objective choice for safety, effectiveness and convenience.
"Oxyglobin is the only oxygen-carrying fluid available off the shelf for dogs in need of oxygen support and no typing or cross-matching of the recipient's blood is required."
Oxyglobin, a sterile formulation of polymerised purified bovine haemoglobin in a balanced salt solution with proven efficacy, is available in single dose 60ml and 125ml infusion bags.
For further information on Oxyglobin, see www.dechra.co.uk
The company provides official veterinarians, meat hygiene inspectors and other technical staff to the regulatory compliance sector, and its other clients include Defra, APHA, the Food Standards Agency, DAERA, AHDB, and several private organisations across the UK.
Hallmark says discussions have been ongoing with FSS since mid-2018, since when the company has faced increasing challenges in recruiting and retaining veterinary staff, as a result of eroding salary values and the weakening pound post-Brexit.
David Peace, Chairman of HallMark Meat Hygiene said: "The position we presented to FSS set out HallMark’s case for a substantial increase in funding to apply entirely to frontline veterinary salaries.
"Starting salaries for veterinary staff working with HallMark in this sector had altered very little during the past twenty years. As a responsible employer and trading partner, and with inflation and a weaker pound severely testing real pay levels, HallMark felt it necessary to address those issues robustly and directly to ensure staff are properly compensated and, as a result, that services are stabilised for the benefit of the Scottish meat industry."
"We’re naturally disappointed to part company with a valued customer such as FSS. By mutual agreement last year, we submitted a business case setting out what we believe is necessary to stabilise and maintain service delivery into the future. Ultimately, FSS decided not to accept that business case, and we consequently requested to be released from our contract with them.”
HallMark says it will continue to provide veterinary and technical services to government departments across the UK. Indeed, only last year HallMark’s parent company acquired MLCLS (Meat and Livestock Commercial Services Limited), the leading independent carcase classification business, originally owned by AHDB. HallMark is also an equal partner in its joint venture company, Probita Solutions Limited, which recruits and deploys vets in support of veterinary practices involved in TB testing activities.
The company also says it will continue to bid for major meat sector tenders in the future.
Mr Peace added: "This news should absolutely not be interpreted as a HallMark withdrawal from meat industry official controls. We will continue to offer the same diligence and dedication to welfare and hygiene standards, wherever opportunities arise, and it will be our mission to offer to government the most efficient and professional compliance services possible, optimising the cost of compliance delivery."